An Open Label PET Imaging Study to Evaluate the mGlu5 Receptor Occupancy Following ADX48621 (Dipraglurant) Administration
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Dipraglurant (Primary)
- Indications Drug-induced dyskinesia; Dystonia
- Focus Pharmacodynamics
- 03 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 03 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.
- 13 Sep 2016 Planned End Date changed from 1 Jun 2016 to 1 Dec 2016.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History